Venus Concept Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $1.64
- Today's High:
- $1.7299
- Open Price:
- $1.7299
- 52W Low:
- $1.515
- 52W High:
- $9.8985
- Prev. Close:
- $1.73
- Volume:
- 1130
Company Statistics
- Market Cap.:
- $9.67 million
- Book Value:
- -1.126
- Revenue TTM:
- $86.43 million
- Operating Margin TTM:
- -39.6%
- Gross Profit TTM:
- $74.09 million
- Profit Margin:
- -48.12%
- Return on Assets TTM:
- -17.91%
- Return on Equity TTM:
- -463.54%
Company Profile
Venus Concept Inc had its IPO on 2012-11-05 under the ticker symbol VERO.
The company operates in the Healthcare sector and Medical Devices industry. Venus Concept Inc has a staff strength of 384 employees.
Stock update
Shares of Venus Concept Inc opened at $1.73 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $1.64 - $1.73, and closed at $1.64.
This is a -5.2% slip from the previous day's closing price.
A total volume of 1,130 shares were traded at the close of the day’s session.
In the last one week, shares of Venus Concept Inc have slipped by -6.29%.
Venus Concept Inc's Key Ratios
Venus Concept Inc has a market cap of $9.67 million, indicating a price to book ratio of 2.2058 and a price to sales ratio of 0.18.
In the last 12-months Venus Concept Inc’s revenue was $86.43 million with a gross profit of $74.09 million and an EBITDA of $-29944000. The EBITDA ratio measures Venus Concept Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Venus Concept Inc’s operating margin was -39.6% while its return on assets stood at -17.91% with a return of equity of -463.54%.
In Q2, Venus Concept Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 26.4%.
Venus Concept Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-8.5 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Venus Concept Inc’s profitability.
Venus Concept Inc stock is trading at a EV to sales ratio of 0.848 and a EV to EBITDA ratio of -2.9982. Its price to sales ratio in the trailing 12-months stood at 0.18.
Venus Concept Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $106.16 million
- Total Liabilities
- $34.94 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $22000
- Dividend Payout Ratio
- 0%
Venus Concept Inc ended 2024 with $106.16 million in total assets and $0 in total liabilities. Its intangible assets were valued at $106.16 million while shareholder equity stood at $-6221000.00.
Venus Concept Inc ended 2024 with $0 in deferred long-term liabilities, $34.94 million in other current liabilities, 30000.00 in common stock, $-241719000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $6.12 million and cash and short-term investments were $6.12 million. The company’s total short-term debt was $9,306,000 while long-term debt stood at $70.68 million.
Venus Concept Inc’s total current assets stands at $75.79 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $37.52 million compared to accounts payable of $8.29 million and inventory worth $22.94 million.
In 2024, Venus Concept Inc's operating cash flow was $0 while its capital expenditure stood at $22000.
Comparatively, Venus Concept Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $1.64
- 52-Week High
- $9.8985
- 52-Week Low
- $1.515
- Analyst Target Price
- $13
Venus Concept Inc stock is currently trading at $1.64 per share. It touched a 52-week high of $9.8985 and a 52-week low of $9.8985. Analysts tracking the stock have a 12-month average target price of $13.
Its 50-day moving average was $1.91 and 200-day moving average was $3.1 The short ratio stood at 9.45 indicating a short percent outstanding of 0%.
Around 508.7% of the company’s stock are held by insiders while 7303.7% are held by institutions.
Frequently Asked Questions About Venus Concept Inc
Similar Industry Stocks (Medical Devices)
Most Active
Top Gainers
Top Losers
About
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.